AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 71 min read$ARCB

MCREYNOLDS JUDY R sold $201K of ARCB (indirect holdings)

MCREYNOLDS JUDY R sold 1,443 indirectly-held shares of ARCBEST CORP /TX/ (ARCB) at $139.30 ($0.20M total) on 2026-08-06.

Original reporting
SEC EDGAR · MCREYNOLDS JUDY R
Published Aug 7, 2026, 2:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 2:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$ARCB
Neutral
medium confidence
Mentioned
$ARCB
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARCBNeutralLow
01

Why it matters

The newest fact is the specific open-market sale details (shares, price, total value, and post-transaction holdings). However, the text provides no operational or financial developments for ARCB.

02

Market read

Traders may note insider selling, but the disclosure alone is unlikely to drive a material repricing without additional company catalysts.

03

What to watch

The transaction is indirect and lacks a stated 10b5-1 plan; without context on total holdings, taxes, or prior sale patterns, interpreting it as a signal is risky.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-07, sale dated 2026-08-06

Background

The article is an SEC Form 4 insider transaction disclosure for ARCB, reported by a director via an indirect holding.

Company-level read

Ticker impact

$ARCBNeutralMedium confidence
Context

ARCB Form 4 shows director MCREYNOLDS Judy R sold 1,443 shares at $139.30 on 2026-08-06 via an indirect holding.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small.

Evidence & confidence

The filing is a Form 4 insider transaction, not an earnings, guidance, or corporate event. The disclosed sale size ($201k) is modest relative to typical market moves, and there is no accompanying company-specific catalyst in the text.

Market effects

Sector

No sector-level implications disclosed; this is company-specific insider trading data.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale could be for diversification or liquidity needs and may not reflect bearish expectations, especially since the filing does not provide intent beyond the transaction code.

Key entities

  • issuer
    ARCB

    Arcbest Corp, the company whose Form 4 insider sale is disclosed.

  • insider
    MCREYNOLDS JUDY R

    Director reporting an indirect open-market sale of ARCB shares.

Read at source← All news

Related articles

AUG 5
$ARCBMed

ArcBest’s Q2 Earnings Call: Our Top 5 Analyst Questions

ArcBest reported Q2 revenue of $1.18B, matching analyst estimates, and adjusted EPS of $2.38 versus $2.26 expected. Adjusted EBITDA was $115M versus $111.7M. Operating margin fell to -1.7% from 3.6% a year earlier, with sales volumes down 2.8% YoY. Management cited pricing discipline, efficiency gains, and noted no broad industrial demand inflection.

financialcontent.com4 min
AUG 1
$ARCBMed

ARCB Q2 Deep Dive: Restructuring and Digital Initiatives Take Center Stage Amid Market Challenges

ArcBest reported Q2 revenue of $1.18B, matching analyst estimates, with adjusted EPS of $2.38 vs $2.26 and adjusted EBITDA of $115M vs $111.7M. Operating margin fell to -1.7% from 3.6% a year earlier, and sales volumes declined 2.8% YoY. The company outlined restructuring and ArcBestView digital initiatives, targeting $40M annualized cost savings and growth in managed solutions.

yahoo.com6 min
JUL 31
$ARCBMed

ArcBest Q2 Earnings Call Highlights

The company expects the initiatives to generate about $40 million in annualized cost savings. Chief Financial Officer Matt Beasley said ArcBest recognized about $2 million of savings in the second quarter and expects approximately $6 million in the third quarter. The company expects to reach the full $10 million quarterly run rate by the first quarter of 2027. About 75% of the $40 million in savings is associated with the asset-based business.

yahoo.com5 min
JUL 31
$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.

yahoo.com7 min
JUL 30
$ARCBMedAI 8/10

ArcBest’s Q2 a step on path to recovery

ArcBest's second-quarter results showed operational improvements in both of its business segments. It is benefitting from heavier shipment weights on the asset-based side of the house while cost initiatives have pushed its logistics offering back into profitability. Shipment weights increasing as TL freight returns ArcBest's (NASDAQ: ARCB) asset-based unit, which includes less-than-truckload subsidiary ABF Freight, reported a 10% y/y increase in revenue to $784 million.

yahoo.com4 min
JUL 29
$ARCBMed

ArcBest reports second quarter loss, affected by restructuring costs | Arkansas Democrat Gazette

ArcBest reported a Q2 GAAP loss of $13.8 million, or 62 cents per share, versus a year-ago profit of $25.8 million, or $1.12 per share. Revenue rose to $1.18 billion from $1.02 billion. Non-GAAP net income was $53.6 million, or $2.38 per diluted share. The results were tied to restructuring costs from a July 16 plan and included $40 million annualized savings.

arkansasonline.com6 min